Clinical Trial Update: A Study to Evaluate Immunotherapy Combinations in Participants With Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating immunotherapy combinations in patients with non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED